Literature DB >> 22116459

Diagnostic dilemmas in retinitis and endophthalmitis.

J L Davis1.   

Abstract

Visual loss in infectious posterior uveitis or panuveitis can occur if proper therapy is delayed because of diagnostic uncertainty. Some disorders, such as acute retinal necrosis and bacterial endophthalmitis, can be rapidly progressive, and therefore require prompt and accurate diagnosis to guide initial therapy. Other more slowly evolving infections, such as toxoplasmic chorioretinitis or fungal endophthalmitis, can be worsened by empiric use of corticosteroids without specific antimicrobial coverage. Key ocular diagnostic features are helpful but highly variable with overlap with both non-infectious uveitis and neoplastic masquerades, even for key signs such as hypopyon. Close examination of the fundus with attention to color, location, size, border, and opacity of lesions and associated arteriolitis or frosted branch angiitis is helpful in the diagnosis of chorioretinitis. Ultrasonography is an important tool in the evaluation of eyes with suspected endophthalmitis, especially those with intracapsular infection or focal infected deposits. Testing of intraocular fluid can be extremely useful but suffers from inaccessibility, poor sensitivity, and test selections dependent on a presumptive diagnosis, which may be wrong. The dilemma for clinician is to make the correct diagnosis of a rare, blinding, variegated disease quickly enough to intercede with specific therapy or to apply empiric therapy in a sufficiently skilled manner to avert disaster and confirm the diagnosis by response to treatment. When non-infectious uveitis is in the differential, empiric corticosteroids must sometimes be used, at great risk, if clinical examination, ancillary testing, and any available intraocular diagnostic tests have failed to confirm a diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 22116459      PMCID: PMC3272204          DOI: 10.1038/eye.2011.299

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  51 in total

1.  Differentiation between presumed ocular histoplasmosis syndrome and multifocal choroiditis with panuveitis based on morphology of photographed fundus lesions and fluorescein angiography.

Authors:  J R Parnell; L M Jampol; L A Yannuzzi; J D Gass; M K Tittl
Journal:  Arch Ophthalmol       Date:  2001-02

2.  Multifocal chorioretinal atrophy associated with herpes zoster ophthalmicus.

Authors:  P A McKelvie; I C Francis; S Watson; G Nuovo
Journal:  Clin Exp Ophthalmol       Date:  2001-12       Impact factor: 4.207

3.  In situ hybridization for the identification of yeastlike organisms in tissue section.

Authors:  R T Hayden; X Qian; G D Roberts; R V Lloyd
Journal:  Diagn Mol Pathol       Date:  2001-03

4.  Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis.

Authors:  Sunao Sugita; Koju Kamoi; Manabu Ogawa; Ken Watanabe; Norio Shimizu; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-27       Impact factor: 3.117

5.  Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis.

Authors:  N A Rao; A A Hidayat
Journal:  Am J Ophthalmol       Date:  2001-08       Impact factor: 5.258

Review 6.  Endogenous endophthalmitis caused by Histoplasma capsulatum var. capsulatum: a case report and literature review.

Authors:  C A Gonzales; I U Scott; N A Chaudhry; K M Luu; D Miller; T G Murray; J L Davis
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis.

Authors:  Bahram Bodaghi; Flore Rozenberg; Nathalie Cassoux; Christine Fardeau; Phuc LeHoang
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

Review 8.  Frosted branch angiitis: a review.

Authors:  S Walker; A Iguchi; N P Jones
Journal:  Eye (Lond)       Date:  2004-05       Impact factor: 3.775

9.  Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis.

Authors:  Darius M Moshfeghi; Emilio M Dodds; Cristóbal A Couto; Carmen I Santos; Donald H Nicholson; Careen Y Lowder; Janet L Davis
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

10.  Multiple evanescent white dot syndrome in patients with multifocal choroiditis.

Authors:  Richard G Bryan; K Bailey Freund; Lawrence A Yannuzzi; Richard F Spaide; Sheau J Huang; Danielle L Costa
Journal:  Retina       Date:  2002-06       Impact factor: 4.256

View more
  7 in total

1.  Current concepts and future directions in the pathogenesis and management of non infectious uveitis.

Authors:  R Agrawal
Journal:  Eye (Lond)       Date:  2012-03-09       Impact factor: 3.775

Review 2.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

3.  A Case of Chorioretinitis with Retinal Angiomatous Proliferation.

Authors:  Yanru Chen; Mingyan Wei; Qian Chen; Minghan Li
Journal:  Case Rep Ophthalmol Med       Date:  2021-12-26

Review 4.  Endogenous Endophthalmitis-The Clinical Significance of the Primary Source of Infection.

Authors:  Małgorzata Gajdzis; Kornelia Figuła; Joanna Kamińska; Radosław Kaczmarek
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

5.  A case of endogenous candida endophthalmitis with incidental cytomegalovirus infection and optic neuropathy in a patient recovered from severe COVID-19.

Authors:  Sanjeewa Kaluarachchi; Muditha Abeykoon
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

Review 6.  Vitreous analysis in the management of uveitis.

Authors:  Erika M Damato; Martina Angi; Mario R Romano; Francesco Semeraro; Ciro Costagliola
Journal:  Mediators Inflamm       Date:  2012-10-24       Impact factor: 4.711

7.  Evaluation of the vitreous microbial contamination rate in office-based three-port microincision vitrectomy surgery using Retrector technology.

Authors:  Flavio A Rezende; Cynthia X Qian; Przemyslaw Sapieha
Journal:  BMC Ophthalmol       Date:  2014-05-01       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.